Cifuentes, Paul

Amgen (United States)

1 paper on CoChatORCID 0000-0001-9303-6819

Most cited papers

Verified
Abstract P05-02: A phase 1b study evaluating the combination of sotorasib, a KRASG12C inhibitor, and afatinib, a pan-ErbB tyrosine kinase inhibitor, in advanced KRAS p.G12C mutated non-small cell lung cancer (NSCLC)
Gandara, D., Marrone, K., Govindan, R., Skoulidis, F., Durm, G., Clarke, J., Frank, R., Krauss, J., Snyder, W., Dai, T., et al. (2021) · Molecular Cancer Therapeutics
Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Cited by 24

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free